The short version of post-marketing surveillance fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-05 and is reviewed periodically as new material appears.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved for therapeutic use | No marketing authorisation from major agencies |
| Legal classification | Varies by jurisdiction | Prescription-only or controlled in several countries |
| Common synonyms | Melanotan II; MT-II | Also referenced by catalogue codes |
| Typical analytical method | Reverse-phase HPLC | Often paired with mass spectrometry |
| Primary literature focus | Receptor pharmacology | Pigmentation and melanocortin signalling |
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The plan was that Johannesburg would revolt and seize the Boer armoury in Pretoria. Jameson and his force would dash across the border to Johannesburg to "restore order" and with control of Johannesburg would control the gold fields. However, while Jameson waited for the insurrection to begin, differences arose within the Reform Committee and between Johannesburg Uitlander reformers regarding the form of government to be adopted after the coup. At a point, certain reformers contacted Jameson to inform him of the difficulties and advised him to stand down. Jameson, with 600 restless men and other pressures, became frustrated by the delays and, believing that he could spur the reluctant Johannesburg reformers to act, decided to go ahead. He sent a telegram on 28 December 1895 to Rhodes warning him of his intentions – "Unless I hear definitely to the contrary, shall leave to-morrow evening" – and on the very next day sent a further message, "Shall leave to-night for the Transvaal". However, the transmission of the first telegram was delayed, so that both arrived at the same time on the morning of 29 December, and by then Jameson's men had cut the telegraph wires and there was no way of recalling him. On 29 December 1895, Jameson's armed column crossed into the Transvaal and headed for Johannesburg. They hoped that this would be a three-day dash to Johannesburg before the Boer commandos could mobilise, and would trigger an uprising by the Uitlanders.
After several years of researching disgust, Jonathan Haidt, and others, studied its opposite; the term "elevation" was coined. Elevation is a pleasant moral emotion, triggered by witnessing virtuous acts of remarkable moral goodness and resulting in a desire to act morally and do "good". As an emotion it has a biological basis, and is sometimes characterized by a feeling of expansion in the chest or a tingling feeling on the skin.
However, 9 November is also the anniversary of the execution of Robert Blum following the 1848 Vienna revolts, the 1923 Beer Hall Putsch and the infamous Kristallnacht pogroms of the Nazis in 1938. Nobel Laureate Elie Wiesel criticised the first euphoria, noting that "they forgot that 9 November has already entered into history—51 years earlier it marked the Kristallnacht." As reunification was not official and complete until 3 October (1990), that day was finally chosen as German Unity Day.
Sources: en.wikipedia.org
Colonial administration records (migrated archives): Malaya at The National Archives (Pg. 52) The UK Statute Law Database: Federation of Malaya Independence Act 1957 (c. 60) United Nations Treaty Collection: No.10760: Agreement relating to Malaysia FEDERATION OF MALAYA AGREEMENT OF 5 AUGUST 1957 Media related to Federation of Malaya at Wikimedia Commons
Potential graphene applications include lightweight, thin, and flexible electric/photonics circuits, solar cells, and various medical, chemical and industrial processes enhanced or enabled by the use of new graphene materials, and favoured by massive cost decreases in graphene production.
Adorno shortly thereafter participated in a meeting with the Berlin Sozialistischer Deutscher Studentenbund (SDS) and discussed "Student Unrest" with Szondi on West German Radio. However, as 1968 progressed, Adorno became increasingly critical of the disruptions students experienced in university life. His isolation was only compounded by articles published in the magazine alternative, which, following the lead of Hannah Arendt's articles in Merkur, claimed Adorno had subjected Benjamin to pressure during his years of exile in Berlin and compiled Benjamin's Writings and Letters with a great deal of bias. In response, Benjamin's longtime friend Gershom Scholem, wrote to the editor of Merkur to express his disapproval of the "in part, shameful, not to say disgraceful" remarks by Arendt. Relations between students and the West German state continued to deteriorate. In spring 1968, a prominent SDS spokesman, Rudi Dutschke, was gunned down in the streets; in response, massive demonstrations took place, directed in particular against the Springer Press, which had led a campaign to vilify the students. An open appeal published in Die Zeit, signed by Adorno, called for an inquiry into the social reasons that gave rise to this assassination attempt as well as an investigation into the Springer Press' manipulation of public opinion. At the same time, however, Adorno protested against disruptions of his own lectures and refused to express his solidarity with their political goals, maintaining instead his autonomy as a theoretician.
== GST-tags and the GST pull-down assay == GST can be added to a protein of interest to purify it from solution in a process known as a pull-down assay. This is accomplished by inserting the GST DNA coding sequence next to that which codes for the protein of interest. Thus, after transcription and translation, the GST protein and the protein of interest will be expressed together as a fusion protein. Because the GST protein has a strong binding affinity for GSH, beads coated with the compound can be added to the protein mixture; as a result, the protein of interest attached to the GST will stick to the beads, isolating the protein from the rest of those in solution. The beads are recovered and washed with free GSH to detach the protein of interest from the beads, resulting in a purified protein. This technique can be used to elucidate direct protein–protein interactions. A drawback of this assay is that the protein of interest is attached to GST, altering its native state. A GST-tag is often used to separate and purify proteins that contain the GST-fusion protein. The tag is 220 amino acids (roughly 26 kDa) in size, which, compared to tags such as the Myc-tag or the FLAG-tag, is quite large. It can be fused to either the N-terminus or C-terminus of a protein. In addition to functioning as a purification tag, GST acts as a chaperone for the attached protein, promoting its correct folding, as well as preventing it from becoming aggregated in inclusion bodies when expressed in bacteria.
Sources: en.wikipedia.org
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.
Much of the evidence comes from case reports and accounts of unregulated use rather than controlled trials. Differences in product purity and dosing add further variability.
Laboratory work focuses on receptor binding and cellular signalling. Observational reports document outcomes after use, and analytical chemists examine samples to assess content and purity.
Only a small number of early-stage human studies have been reported, and most were limited in size and duration. No large late-stage program has established a general efficacy or safety profile. The evidence base is therefore thin compared with approved medicines.